Schedule D outlines the substances not intended for medicinal use, detailing the requirements for importation and labeling. Schedule D(i) and D(ii) specify the information and undertakings needed for manufacturers applying for registration of drugs, covering aspects such as manufacturing details and clinical documentation. The document emphasizes compliance with standards and conditions set forth in relevant acts and rules.